Outcome of dialectical behaviour therapy for concurrent eating and XXXX .

@entity1 @entity308 @entity2613 @entity1277 @entity20207 @entity734
AIM: The current study examined the preliminary efficacy of dialectical behaviour therapy ( @entity20207 ) adapted for concurrent @entity1277 ( @entity1277 ) and @entity734 ( @entity734 ). METHOD: A matched randomized controlled trial was carried out with 25 female outpatients diagnosed with concurrent @entity2613 and SUD. @entity1 randomized to the intervention condition received @entity20207 , whereas those randomized to the control condition received treatment as usual (TAU), both for a period of 1   year. A series of measures related to @entity1277 , substance use and @entity308 were administered to the @entity1 at the beginning of treatment and at 3, 6, 9 and 12 months into treatment, followed by 3-month and 6-month follow-up assessments. FINDINGS: @entity1 randomized to the @entity20207 condition evidenced a superior retention rate relative to their counterparts in the TAU condition at various study time points, including post-treatment (80% versus 20%) and follow-up (60% versus 20%). Due to the unexpected elevated dropout rates and the worsening of @entity2613 -SUD symptomatology in the TAU condition, recruitment efforts were terminated early. Results from the @entity20207 condition revealed that the intervention had a significant positive effect on behavioural and attitudinal features of @entity1277 , substance use severity and use, negative mood regulation and @entity308 . Finally, increases in @entity1 ' perceived ability to regulate and cope with negative emotional states were significantly associated with @entity1277 and increases in levels of confidence in ability to resist urges for substance use. CONCLUSION: Results suggest that the adapted @entity20207 might hold promise for treating individuals with concurrent @entity2613 and SUD. KEY PRACTITIONER MESSAGE: The current study is the first study to report positive effects of @entity20207 on individuals with concurrent eating and @entity734 . Although the results require replication and extension, they suggest that the @entity20207 may be promising for this population. The results suggest that clinicians treating individuals with concurrent eating and substance use problems should be particularly cautious of poor treatment retention and treatment complications. The results bear upon the highly salient and important issue of whether individuals with concurrent substance use need to be excluded from research studies and treatment programmes.
